What is ?

(also known as Citrate or ) is a non-steroidal selective estrogen receptor modulator (SERM) that acts as a pure estrogen receptor antagonist. Unlike standard clomiphene mixtures which contain a blend of both estrogenic and anti-estrogenic isomers, isolates the active trans-isomer to deliver targeted anti-estrogenic effects without conflicting estrogenic signaling. Researchers study this compound primarily for its ability to stimulate endogenous hormone cascades, address secondary hypogonadism, and maintain spermatogenesis.

For laboratory and in vitro evaluation, researchers often choose to buy in high-purity research chemical in liquid form. Suspensions such as these are stabilized using DMSO and PEG-400 to preserve structural compound distribution during cellular screening assays.

Chemical and Molecular Data

What are the Mechanisms of Action?

The biochemical pathways and cellular targets of include:

• Selective Pituitary Antagonism: binds directly to estrogen receptors within the hypothalamus and pituitary gland, acting as a competitive antagonist that interrupts the natural negative feedback loop of endogenous estrogen.
• Gonadotropin Upregulation: By blocking local estrogenic signaling, the compound prompts the hypothalamus to increase the secretion of Gonadotropin-Releasing Hormone (GnRH), subsequently accelerating pituitary release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).
• Spermatogenesis Preservation: Increased intratesticular testosterone levels are achieved via endogenously stimulated Leydig cells, which uniquely avoids the suppression of spermatogenesis typically associated with exogenous hormone vectors.

What are the Clinical & Preclinical Trials on ?

When evaluating research efficacy and published experimental literature for :

• Testosterone Restoration Dynamics: A clinical trial published in PMC evaluated the pharmacodynamics of oral citrate, demonstrating consistent, rapid elevation of serum LH and total testosterone levels into the normal eugonadal range within two weeks of tracking.
• Sperm Count Retention Evaluations: Investigations cataloged in PubMed compared citrate directly to transdermal testosterone gels, noting that while both modalities restored systemic androgen metrics, only preserved or improved baseline sperm concentrations.
• Metabolic Safety Profiles: Multicentre trials indexed in PMC document that isolated administrations demonstrate a clear absence of deleterious shifts across blood lipids, fasting glucose parameters, or vital organ function safety markers.

How does compare to other compounds?

To evaluate target specificity and relative potencies, researchers compare against traditional isomer blends and alternative hormone-modulating reference agents: